GlassScriptPhysician profile
Christian A Hall
NPI 1134282957
$5,395.62
in general payments reported to CMS, 2019-2025
29 companies · $1,280 in 2025
The $1,280 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $658 · 2021: $994 · 2022: $585 · 2023: $970 · 2024: $475 · 2025: $1,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191 · Consulting Fee: $500 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,190.63 |
| Consulting Fee | $500.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $1,240.42 | 2019-2025 | |
| Glaxosmithkline, LLC. | $632.32 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Spirair, INC. | $575.16 | 2024-2025 | Septalign |
| Regeneron Healthcare Solutions, INC. | $532.84 | 2019-2025 | Dupixent |
| Genzyme Corporation | $475.41 | 2019-2025 | |
| Medtronic, INC. | $317.42 | 2021-2024 | Propel, Aquamantys(Tm) |
| Aerin Medical INC. | $263.10 | 2020-2025 | |
| Alk-Abello, INC | $215.61 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Acclarent, INC | $185.90 | 2019-2023 | Acclarent Aera |
| Inspire Medical Systems, INC. | $148.64 | 2023-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $140.86 | 2021-2023 | |
| Stryker Corporation | $137.29 | 2019-2025 | Nasopore, Scopis Ent |
| Biohaven Pharmaceuticals, INC. | $79.44 | 2021 | |
| Abbvie INC. | $55.18 | 2021-2022 | |
| Kaleo, INC. | $42.19 | 2019-2023 | Auvi-Q |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $41.54 | 2021 | |
| Amgen INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $33.70 | 2024-2025 | Ryaltris |
| Merck Sharp & Dohme LLC | $30.79 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $30.28 | 2021-2025 | Tezspire |
| Medtronic USA, INC. | $29.32 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $29.17 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $24.28 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Ars Pharmaceuticals Operations, INC. | $23.05 | 2025 | Neffy |
| Icu Medical INC | $19.71 | 2023 | Bluselect Tracheostomy Tube |
| Biohaven Pharmaceutical Holding Company LTD. | $16.60 | 2022 | |
| Pfizer INC. | $16.16 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.31 | 2025 | Xhance |
| Almirall LLC | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.